헬스케어 바이오컨버전스 시장 : 기술별, 솔루션 종류별, 용도별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

REPORT HIGHLIGHT

Healthcare Bioconvergence Market size was valued at US$ 143,920.32 Million in 2024, expanding at a CAGR of 6.90% from 2025 to 2032.

The Healthcare Bioconvergence Market integrates biology, engineering, and data science to drive innovation in diagnostics, drug development, and personalized medicine. Bioconvergence refers to the fusion of biological and technological disciplines to enhance healthcare solutions. Advances in synthetic biology, nanotechnology, and artificial intelligence are transforming medical research and patient care. For instance, researchers at MIT have developed AI-powered drug discovery platforms that reduce development time by nearly 50%. The increasing prevalence of chronic diseases, demand for precision medicine, and government initiatives supporting biotech innovation are fueling growth. However, high R&D costs and regulatory complexities pose challenges. The emergence of bio-integrated wearable devices, lab-on-a-chip technology, and 3D bioprinting presents lucrative opportunities. Companies like Moderna and BioNTech are leveraging bioconvergence to enhance mRNA-based therapies, demonstrating the potential for disruptive innovations in treatment. Additionally, collaborations between biotech firms and semiconductor manufacturers, such as Intel's AI-driven healthcare initiatives, are expanding the market's technological scope. The future of healthcare bioconvergence lies in bridging biology with advanced computational and engineering solutions.

Healthcare Bioconvergence Market- Market Dynamics

**Advancements in AI-Powered Drug Discovery accelerating the market growth**

AI-powered drug discovery is revolutionizing the healthcare bioconvergence market by accelerating the identification of novel therapeutics and optimizing treatment development. Leading pharmaceutical firms and biotech startups are integrating AI with biological data to enhance precision medicine and streamline drug screening. For instance, the FDA has approved AI-driven platforms for drug repurposing, while companies like Insilico Medicine and BenevolentAI are utilizing deep learning to identify promising drug candidates. Moreover, AI-driven algorithms are being used in genomics to analyze vast datasets, aiding in early disease detection. The National Institutes of Health (NIH) has funded multiple AI-based research projects to improve drug efficacy and reduce development timelines. With AI reducing costs and enhancing efficiency, pharmaceutical companies are increasingly collaborating with tech firms to leverage machine learning in drug discovery. However, regulatory challenges and data privacy concerns remain key hurdles in fully realizing AI's potential in drug development. Despite these challenges, the ongoing convergence of AI and biotechnology is set to reshape modern medicine.

Healthcare Bioconvergence Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.90% over the forecast period (2025-2032)

Based on Technology segmentation, AI & Big Data Integration was predicted to show maximum market share in the year 2024

Based on Solution Type segmentation, Biopharmaceuticals was the leading Solution Type in 2024

Based on Application segmentation, Personalized Medicine was the leading Application in 2024

On the basis of region, North America was the leading revenue generator in 2024

Healthcare Bioconvergence Market- Segmentation Analysis:

The Global Healthcare Bioconvergence Market is segmented on the basis of Technology, Solution Type, Application, End-User, and Region.

The market is divided into four categories based on Technology: Synthetic Biology, Bioelectronics, Nanotechnology, and AI & Big Data Integration. AI & Big Data Integration leads the healthcare bioconvergence market, driving personalized medicine and predictive analytics. Synthetic Biology follows, revolutionizing gene editing and biomaterials. Nanotechnology ranks next, enabling targeted drug delivery. Bioelectronics holds significant potential, enhancing neurostimulation and real-time health monitoring applications.

The market is divided into four categories based on Solution Type: Biopharmaceuticals, Tissue Engineering, Biosensors, and AI-driven Diagnostics. Biopharmaceuticals dominate the healthcare bioconvergence market, driving advancements in targeted therapies and regenerative medicine. AI-driven Diagnostics follows, revolutionizing early disease detection and precision medicine. Tissue Engineering ranks next, enabling organ regeneration. Biosensors play a crucial role in real-time monitoring and personalized healthcare solutions.

Healthcare Bioconvergence Market- Geographical Insights

North America dominates the healthcare bioconvergence market, driven by strong investments in biotechnology, artificial intelligence (AI), and precision medicine. The U.S., home to major biotech firms and research institutions, has seen increasing collaborations between pharmaceutical companies and AI-driven startups. Government initiatives, such as the NIH's AI-driven research programs, further support market growth. Europe follows closely, with countries like Germany, the UK, and France advancing in synthetic biology, bioengineering, and digital health innovations. The European Commission has launched funding programs to promote bioconvergence research. In the Asia-Pacific region, China, Japan, and South Korea are rapidly expanding their biotech and AI capabilities, fueled by government policies and private sector investments. China, in particular, is leading in gene editing and AI-driven diagnostics. Meanwhile, the Middle East and Latin America are emerging players, with growing investments in personalized medicine and bioinformatics. However, regulatory complexities and ethical concerns around AI and genetic modifications pose challenges to market expansion across different regions.

Healthcare Bioconvergence Market- Competitive Landscape:

The healthcare bioconvergence market is highly competitive, with key players focusing on integrating biotechnology, artificial intelligence (AI), nanotechnology, and engineering to drive medical innovations. Leading pharmaceutical companies such as Pfizer, Novartis, and Roche are investing in AI-powered drug discovery and bioengineering solutions. Tech firms like IBM Watson Health and Google DeepMind are enhancing precision medicine through machine learning and computational biology. Startups such as Insilico Medicine and BenevolentAI are gaining traction with AI-driven drug development platforms. Additionally, academic institutions and research centers, including MIT and the Broad Institute, are playing a crucial role in advancing synthetic biology and bioinformatics. Mergers, acquisitions, and strategic partnerships are shaping the competitive landscape, with companies collaborating to leverage AI and biomolecular advancements. Government funding and venture capital investments further drive innovation, particularly in North America and Europe. However, challenges such as regulatory approvals, data privacy concerns, and the high cost of technology integration continue to impact market expansion and competition.

Recent Developments:

In February 2023, Peregrine Ventures launched new 'bioconvergence' startups, combining technologies from diverse fields to develop innovative life sciences products.

In October 2022, Century Therapeutics and Bristol Myers Squibb partnered to develop and commercialize iPSC-derived allogenic cell therapies, enhancing their market presence and advancing personalized medicine through collaborative innovation in regenerative treatments.

In May 2022, Israel launched a five-year, $127 million bio-convergence strategy, focusing on infrastructure for industrial R&D and company consortiums to integrate biology with electronics, physics, computer science, and advanced genetic engineering.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEALTHCARE BIOCONVERGENCE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Adaptive Biotechnologies Corporation
• Atomwise, Inc.
• Berkeley Lights, Inc.
• BGI Genomics Co., Ltd.
• BioNTech SE
• Codexis, Inc.
• Deep Genomics Inc.
• Ginkgo Bioworks Holdings, Inc.
• Illumina, Inc.
• Inscripta, Inc.
• Moderna, Inc.
• NanoString Technologies, Inc.
• Oxford Nanopore Technologies plc
• Pacific Biosciences of California, Inc.
• Thermo Fisher Scientific Inc.
• Twist Bioscience Corporation
• Others

GLOBAL HEALTHCARE BIOCONVERGENCE MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

• Synthetic Biology
• Bioelectronics
• Nanotechnology
• AI & Big Data Integration

GLOBAL HEALTHCARE BIOCONVERGENCE MARKET, BY SOLUTION TYPE- MARKET ANALYSIS, 2019 - 2032

• Biopharmaceuticals
• Tissue Engineering
• Biosensors
• AI-driven Diagnostics

GLOBAL HEALTHCARE BIOCONVERGENCE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Drug Discovery
• Personalized Medicine
• Regenerative Medicine
• Bioelectronics
• Nanorobotics for Drug Delivery
• Diagnostic and Biological Sensor
• Engineered Living Materials
• Optogenetics

GLOBAL HEALTHCARE BIOCONVERGENCE MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

• Pharmaceutical Companies
• Biotech Firms
• Research Institutions
• Diagnostic Labs

GLOBAL HEALTHCARE BIOCONVERGENCE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Healthcare Bioconvergence Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Healthcare Bioconvergence Market Snippet by Technology
  • 2.1.2. Healthcare Bioconvergence Market Snippet by Solution Type
  • 2.1.3. Healthcare Bioconvergence Market Snippet by Application
  • 2.1.4. Healthcare Bioconvergence Market Snippet by End-User
  • 2.1.5. Healthcare Bioconvergence Market Snippet by Country
  • 2.1.6. Healthcare Bioconvergence Market Snippet by Region
• 2.2. Competitive Insights

3. Healthcare Bioconvergence Key Market Trends

• 3.1. Healthcare Bioconvergence Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Healthcare Bioconvergence Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Healthcare Bioconvergence Market Opportunities
• 3.4. Healthcare Bioconvergence Market Future Trends

4. Healthcare Bioconvergence Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Healthcare Bioconvergence Market: Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. Healthcare Bioconvergence Market Landscape

• 6.1. Healthcare Bioconvergence Market Share Analysis, 2024
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Healthcare Bioconvergence Market - By Technology

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
  • 7.1.2. Synthetic Biology
  • 7.1.3. Bioelectronics
  • 7.1.4. Nanotechnology
  • 7.1.5. AI & Big Data Integration

8. Healthcare Bioconvergence Market - By Solution Type

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Solution Type, 2024 & 2032 (%)
  • 8.1.2. Biopharmaceuticals
  • 8.1.3. Tissue Engineering
  • 8.1.4. Biosensors
  • 8.1.5. AI-driven Diagnostics

9. Healthcare Bioconvergence Market - By Application

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
  • 9.1.2. Drug Discovery
  • 9.1.3. Personalized Medicine
  • 9.1.4. Regenerative Medicine
  • 9.1.5. Bioelectronics
  • 9.1.6. Nanorobotics for Drug Delivery
  • 9.1.7. Diagnostic and Biological Sensor
  • 9.1.8. Engineered Living Materials
  • 9.1.9. Optogenetics

10. Healthcare Bioconvergence Market - By End-User

• 10.1. Overview
  • 10.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
  • 10.1.2. Pharmaceutical Companies
  • 10.1.3. Biotech Firms
  • 10.1.4. Research Institutions
  • 10.1.5. Diagnostic Labs

11. Healthcare Bioconvergence Market- By Geography

• 11.1. Introduction
  • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
• 11.2. North America
  • 11.2.1. Overview
  • 11.2.2. Healthcare Bioconvergence Key Manufacturers in North America
  • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.2.5. North America Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
  • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.2.8. U.S.
    • 11.2.8.1. Overview
    • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.2.8.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.8.4. U.S. Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.2.9. Canada
    • 11.2.9.1. Overview
    • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.2.9.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.9.4. Canada Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 11.3. Europe
  • 11.3.1. Overview
  • 11.3.2. Healthcare Bioconvergence Key Manufacturers in Europe
  • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.3.5. Europe Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
  • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.8. Germany
    • 11.3.8.1. Overview
    • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.8.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.8.4. Germany Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.9. UK
    • 11.3.9.1. Overview
    • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.9.3. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.9.4. UK Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.9.6. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.10. France
    • 11.3.10.1. Overview
    • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.10.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.10.4. France Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.10.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.11. Italy
    • 11.3.11.1. Overview
    • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.11.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.11.4. Italy Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.11.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.12. Spain
    • 11.3.12.1. Overview
    • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.12.3. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.12.4. Spain Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.12.6. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.13. The Netherlands
    • 11.3.13.1. Overview
    • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.13.3. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.13.4. The Netherlands Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.13.6. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.14. Sweden
    • 11.3.14.1. Overview
    • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.14.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.14.4. Sweden Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.14.6. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.15. Russia
    • 11.3.15.1. Overview
    • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.15.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.15.4. Russia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.15.6. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.16. Poland
    • 11.3.16.1. Overview
    • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.16.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.16.4. Poland Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.16.6. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.17. Rest of Europe
    • 11.3.17.1. Overview
    • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 11.4. Asia Pacific (APAC)
  • 11.4.1. Overview
  • 11.4.2. Healthcare Bioconvergence Key Manufacturers in Asia Pacific
  • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.4.4. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.4.5. APAC Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
  • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4.7. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.8. China
    • 11.4.8.1. Overview
    • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.8.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.8.4. China Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.8.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.9. India
    • 11.4.9.1. Overview
    • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.9.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.9.4. India Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.9.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.10. Japan
    • 11.4.10.1. Overview
    • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.10.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.10.4. Japan Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.11. South Korea
    • 11.4.11.1. Overview
    • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.11.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.11.4. South Korea Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.12. Australia
    • 11.4.12.1. Overview
    • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.12.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.12.4. Australia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.13. Indonesia
    • 11.4.13.1. Overview
    • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.13.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.13.4. Indonesia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.13.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.14. Thailand
    • 11.4.14.1. Overview
    • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.14.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.14.4. Thailand Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.14.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.15. Philippines
    • 11.4.15.1. Overview
    • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.15.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.15.4. Philippines Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.16. Rest of APAC
    • 11.4.16.1. Overview
    • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.16.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.16.4. Rest of APAC Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 11.5. Latin America (LATAM)
  • 11.5.1. Overview
  • 11.5.2. Healthcare Bioconvergence Key Manufacturers in Latin America
  • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.5.4. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.5.5. LATAM Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
  • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.5.7. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5.8. Brazil
    • 11.5.8.1. Overview
    • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.8.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.8.4. Brazil Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5.9. Mexico
    • 11.5.9.1. Overview
    • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.9.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.9.4. Mexico Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5.10. Argentina
    • 11.5.10.1. Overview
    • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.10.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.10.4. Argentina Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5.11. Colombia
    • 11.5.11.1. Overview
    • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.11.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.11.4. Colombia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5.12. Rest of LATAM
    • 11.5.12.1. Overview
    • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 11.6. Middle East and Africa (MEA)
  • 11.6.1. Overview
  • 11.6.2. Healthcare Bioconvergence Key Manufacturers in Middle East and Africa
  • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.6.4. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.6.5. MEA Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
  • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6.7. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6.8. Saudi Arabia
    • 11.6.8.1. Overview
    • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6.9. United Arab Emirates
    • 11.6.9.1. Overview
    • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6.10. Israel
    • 11.6.10.1. Overview
    • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.10.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.10.4. Israel Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6.11. Turkey
    • 11.6.11.1. Overview
    • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.11.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.11.4. Turkey Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6.12. Algeria
    • 11.6.12.1. Overview
    • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.12.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.12.4. Algeria Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6.13. Egypt
    • 11.6.13.1. Overview
    • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.13.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.13.4. Egypt Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6.14. Rest of MEA
    • 11.6.14.1. Overview
    • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.14.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.14.4. Rest of MEA Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Healthcare Bioconvergence Industry

• 12.1. Competitive Dashboard
  • 12.1.1. Competitive Benchmarking
  • 12.1.2. Competitive Positioning
• 12.2. Company Profiles
  • 12.2.1. Adaptive Biotechnologies Corporation
  • 12.2.2. Atomwise, Inc.
  • 12.2.3. Berkeley Lights, Inc.
  • 12.2.4. BGI Genomics Co., Ltd.
  • 12.2.5. BioNTech SE
  • 12.2.6. Codexis, Inc.
  • 12.2.7. Deep Genomics Inc.
  • 12.2.8. Ginkgo Bioworks Holdings, Inc.
  • 12.2.9. Illumina, Inc.
  • 12.2.10. Inscripta, Inc.
  • 12.2.11. Moderna, Inc.
  • 12.2.12. NanoString Technologies, Inc.
  • 12.2.13. Oxford Nanopore Technologies plc
  • 12.2.14. Pacific Biosciences of California, Inc.
  • 12.2.15. Thermo Fisher Scientific Inc.
  • 12.2.16. Twist Bioscience Corporation
  • 12.2.17. Others

13. 360 Degree AnalystView

14. Appendix

• 14.1. Research Methodology
• 14.2. References
• 14.3. Abbreviations
• 14.4. Disclaimer
• 14.5. Contact Us